Arterial Embolization for the Treatment of Bone Metastases: Prospective Observational Study
ConditionBone Metastases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIstituto Ortopedico Rizzoli
About this trial
To date, arterial embolization constitutes one of the most popular methods in minimally invasive treatment of bone metastases, allowing good results in terms of pain reduction, local control of disease and reduction of peri-operative bleeding, with low invasiveness.
Eligibility criteria
Qualifiers
Patients of either sex of age or older who are candidates for embolization therapy
Life expectancy > 3 months
Single metastatic or oligometastatic.
Plurimetastatic if a particular site is causing painful symptoms or at risk for pathologic rupture
Disqualifiers
Patients with life expectancy <3 months or severe functional status impairment (ASA 4)
Patients with hypovascular metastasis documented by angiography or MRI perfusion study with MDC.
Patients with coagulation deficiency or plateletopenic patients.
Patients with documented active infection.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov